Publications by authors named "Jan Braess"

Claim this Profile
M
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).
Monica Cusan, Karilyn Larkin, Deedra Nicolet, Vindi Jurinovic, Krzysztof Mrózek, Jan Braess

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia.
Eva Telzerow, Dennis Görlich, Cristina Sauerland, Maja Rothenberg-Thurley, Anna Sophia Moret, Jan Braess

Leukemia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.
Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner, Maximillian-Alexander Röhnert, Christian Rausch, Jan Braess

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.
Katja Krüger, Razif Gabdoulline, Martin Wichmann, Bernhard M W Schmidt, Katharina Götze, Jan Braess

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences.
Simon M Krauß, Eva Telzerow, Daniel Richter, Anna S Moret, Maja Rothenberg-Thurley, Jan Braess

Hemasphere· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia.
Kellie J Archer, Han Fu, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, Jan Braess

Innovation (Camb)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How accurate is clinical prognostication by oncologists during routine practice in a general hospital and can it be improved by a specific prognosis training programme: a prospective interventional study.
Irma Kupf, Gabriele Thanner, Michael Gerken, Alexander Crispin, Jan Braess

BMJ Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.
Kellie J Archer, Han Fu, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, Jan Braess

J Hematol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Jan A Stratmann, Friederike C Althoff, Paula Doebel, Jacqueline Rauh, Arne Trummer, Jan Braess

Eur J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of CEBPA mutational subgroups in adult AML.
Julia-Annabell Georgi, Sebastian Stasik, Michael Kramer, Manja Meggendorfer, Christoph Röllig, Jan Braess

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Friday Leukemia-a Structural Phenomenon.
Christian Rausch, Chiara Arnreich, Maja Rothenberg-Thurley, Annika Dufour, Stephanie Schneider, Jan Braess

Dtsch Arztebl Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Stefan Habringer, Uta M Demel, Anne-Katrin Fietz, Felicitas Lammer, Roland Schroers, Jan Braess

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, Ayse S Yilmaz, Jessica Kohlschmidt, Jan Braess

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Jan-Niklas Eckardt, Marius Bill, Christian Rausch, Klaus Metzeler, Karsten Spiekermann, Jan Braess

Leukemia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.
Friederike Pastore, Hanna Gittinger, Susanne Raab, Sebastian Tschuri, Bianka Ksienzyk, Jan Braess

Br J Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.
Elisabeth Meedt, Daniela Weber, Agnes Bonifacius, Britta Eiz-Vesper, Britta Maecker-Kolhoff, Jan Braess

Clin Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.
Christian Rausch, Maja Rothenberg-Thurley, Annika Dufour, Stephanie Schneider, Hanna Gittinger, Jan Braess

Leukemia· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles.
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, Peter Heisig, Sebastian Stasik, Jan Braess

Commun Med (Lond)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indurated erythema of abdominal skin: An unusual presentation of metastatic endometrial carcinoma-Case report with literature review.
Dennis Niebel, Paula Kranert, Mark Berneburg, Konstantin Drexler, Maria Isabel von Eichborn, Jan Braess

Skin Health Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, Michael Kramer, Sebastian Stasik, Jan Braess

Haematologica· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML.
Aarif M N Batcha, Nele Buckup, Stefanos A Bamopoulos, Vindi Jurinovic, Maja Rothenberg-Thurley, Jan Braess

Blood Adv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender Differences in Symptom Burden, Functional Performance and Global Quality of Life of Lung Cancer Patients Receiving Inpatient versus Outpatient Treatment.
Myriam Koch, Tobias Rothammer, Frederike Rasch, Karolina Müller, Jan Braess

Cancer Manag Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis.
Friederike Pastore, Alessandro Pastore, Maja Rothenberg-Thurley, Klaus H Metzeler, Bianka Ksienzyk, Jan Braess

Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
Desiree Kunadt, Sebastian Stasik, Klaus H Metzeler, Christoph Röllig, Christoph Schliemann, Jan Braess

J Hematol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
Jan M Middeke, Klaus H Metzeler, Christoph Röllig, Michael Krämer, Jan-Niklas Eckardt, Jan Braess

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis